The MD-CARE Act, a piece of legislation designed to accelerate research and provide infrastructure needed for the development of new treatments to treat all nine forms of muscular dystrophy, has passed in the Senate by unanimous consent on September 18th. The Muscular Dystrophy Association (MDA), which has been a major advocate for passage of…
News
Recent Posts
- Living with Duchenne grants me unique insight into accessible design
- MDA 2026: FDA decision on deramiocel for DMD expected by August
- MDA 2026: Dyne therapy boosts strength, cognition in DM1
- MDA 2026: Duvyzat shows DMD benefits even at lower dose levels
- Finding time for some quiet thoughts amid the travel and doctor visits